Abstract: The present invention relates to a bicyclic compound of Formula (I) and to a composition for a cosmetic and therapeutic use and to a composition comprising an acceptable vehicle and an effective amount of the compound of Formula (I):

Abstract: A parenteral azole composition comprises a first solvent, made of benzyl alcohol and/or an acidified alcohol such as ethanol, and a lipophilic component such as PEG400, and the azole, or triazole, such as itraconazole or posaconazole dissolved in this first composite solvent vehicle that is essentially free of surfactants, particularly non-ionic surfactants, and has low levels of water, preferably less than 5% water. The composition may be further diluted with an infusion fluid, such as normal saline or 5% or 10% dextrose in water, before infusion into an immunocompromized mammal, preferably a human. The composition is useful for the treatment and suppression of infections caused by microbes such as yeast and molds that are sensitive to azoles, but it may be extended to dissolve other pharmaceutically active agents that can be used to treat other types of infectious diseases or other ailments, such as malignant and autoimmune diseases.

Abstract: Antioxidant-containing compositions and methods for confirming antioxidant activity of a composition formulated for topical application to skin. Methods for testing a composition for ability to inhibit both ultraviolet radiation-induced lipid peroxidation on skin and ultraviolet radiation-induced reactive oxygen species formation in the stratum corneum. Compositions and methods for treating and preventing photodamage to skin.

Abstract: This invention relates to personal care compositions and methods of treating topical skin conditions using compositions containing polymeric sulfur Sn. The compositions of this invention may also preferably contain —SH-containing compounds such as thiols.

Abstract: The present invention relates to a colouring composition to be used in the manufacture of food and pharmaceutical products.

Abstract: The present disclosure provides fibrous composition comprising a soluble or a dispersible N-halamine, for example 1-chloro-2,2,5,5-tetramethyl-4-imidazolidinone (i.e., compound I). Additionally, the disclosure provides methods for producing the fibrous compositions comprising a soluble or a dispersible N-halamine as well as methods for protecting a person from an infection using the fibrous compositions comprising a soluble or a dispersible N-halamine. The compositions and methods according to the present disclosure provide several advantages, such as stability, less time to provide sufficient antimicrobial inactivation, and are inexpensive and require lower amount of active concentrations to be effective.

Abstract: A process for the preparation of a particle, wherein the particle comprises: (a) a core comprising a hydrophobic benefit agent; (b) an outer crosslinked shell, which comprises a crosslinked, hydrophobically modified polyvinyl alcohol, which comprises a crosslinking agent comprising a first dextran aldehyde having a molecular weight of from 2,000 to 2,000,000 Da; and (c) an inner polyamide shell, wherein the shell comprises a polyamide, and wherein the polyamide comprises an aromatic group; wherein the outer crosslinked shell is formed prior to the formation of the inner polyamide shell.

Abstract: A method and system to prevent sore throat infections in humans includes the administration of an active ingredient to a site on the mucus membranes of the throat of a human that inhibits adherence and promotes desorption of S. pyogenes to soft tissue surfaces, such as the pharyngeal and oral mucosa of a human. A mucoadhesive strip having a surface topography that resists bioadhesion of undesired bacteria that are typically present in a human's mouth is preferably employed and that has one or more encapsulated agents selected from the group consisting of an antibiotic; lactic acid bacteria; S. pyogenes modified by a CRISPR-Cas system to reduce one or more virulence factors; and a breath mint solution.

Abstract: The present invention relates to a cosmetic composition, in the form of an oil-in-water emulsion, characterized in that it comprises a 2-acrylamido-2-methylpropanesulfonic acid polymer, a copolymer of 2-acrylamido-2-methylpropanesulfonic acid and of an alcohol(meth)acrylate, and a hydrophobic-modified inulin-based amphiphilic polymer, the globules of the said emulsion having a mean size ranging from 15 to 500 microns and the oily phase being present in an amount of less than 35% by weight relative to the total weight of the composition. The invention also relates to a cosmetic process for treating keratin materials.

Abstract: Certain aspects of the invention relate to compositions comprising UV blocking agents, a film forming polymer containing acid groups and a neutralizing agent. Such compositions have an increased SPF due to neutralization of at least a portion of the acid groups of the film forming agent by the neutralizing agent. The invention also discloses methods for increasing SPF of a composition as well as methods for using the novel composition.

Abstract: In a patch comprising a support layer and an adhesive agent layer, the adhesive agent layer comprises free asenapine, a maleic acid alkali salt, and a rubber-based adhesive agent.

Abstract: A method and system for addressing the avoidance of migraines, cluster headaches and dizziness by adjusting an individual's microbiome, and in particular, to the provision of beneficial oral and gut microbes at particular times to enhance a person's oral health, including through the use of oral strips that adhere to surfaces in the oral cavity.

Abstract: The invention features a method of improving the growth of a plant, involving applying to a seed or locus thereof a composition comprising an active ingredient and a pH-dependent film-forming polymer, followed by exposing the composition to an appropriate pH to release said active ingredient. The invention further features a seed including a composition having a) an active ingredient; and b) a pH-dependent film-forming polymer. Additionally, the invention features a seed treatment composition that includes a) an agrochemical; b) a pH-dependent film-forming polymer; and c) a seed coating agent.

Abstract: The present invention relates to a composition comprising a mixture: of hydrophobic silica aerogel particles having a specific surface area per unit of mass (SM) ranging from 500 to 1500 m2/g and a size expressed as the volume-average diameter (D[0.5]) ranging from 1 to 1500 ?m, and of at least one first linear silicone oil having a viscosity greater than 50 mm2/s and of at least second and third linear silicone oils having a viscosity less than or equal to 50 mm2/s. The present invention also relates to a cosmetic composition comprising a mixture: of hydrophobic silica aerogel particles having a specific surface area per unit of mass (SM) ranging from 500 to 1500 m2/g and a size expressed as the volume-average diameter (D[0.5]) ranging from 1 to 1500 ?m, and of at least one first linear silicone oil having a viscosity less than 10 mm2/s and of at least one second linear silicone oil having a viscosity greater than or equal to 10 mm2/s.

Abstract: The invention provides compositions, kits, and methods for treatment of neuronal injury. In one embodiment, the composition comprises a biomembrane sealing agent, such as PEG, and a bioactive agent, such as a magnesium compound. The biomembrane sealing agent and/or the bioactive agent an intravenous administration, an intramuscular administration, an intrathecal administration, a subcutaneous administration, an epidural administration, a parenteral administration, a direct application onto or adjacent to a site of the pathological condition, and any combinations thereof. Alternatively, the biomembrane sealing agent and/or the bioactive agent may be delivered from a pump or an implant.

Abstract: A non-irritating personal lubricant composition comprises a silicone fluid carrier and at least one sensorial agent, the composition having a viscosity of at least 175 centistokes.

Abstract: The present invention relates to the use of a specific organic compound as flavor and fragrance material. Furthermore the invention relates to flavor and fragrance formulations comprising such a specific organic compound.

Abstract: A depot precursor formulation comprising: a) a controlled-release matrix; b) at least oxygen containing organic solvent; c) at least 12% by weigh of at least one active agent selected from buprenorphine and salts thereof, calculated as buprenorphine free base. Corresponding depot compositions and methods of treatment in pain management, by opioid maintenance and related methods are provided.

Abstract: Disclosed herein are compositions and methods for treating a variety of mood and behavioral disorders, including attention deficit hyperactivity disorder (ADHD), anxiety, depression, memory loss, as well as other conditions. Also disclosed herein are methods for diagnosing certain conditions, such as ADHD, using these compositions.

Abstract: There is disclosed a method for treating disorders modulated by at least opiate receptor activity or monoamine activity, including acute and chronic pain, comprising administering a pharmaceutical formulation comprising O-desmethyltramadol. Methods are also provided that are effective for overcoming resistance to tramadol in patients.